2026年 February 4, 2026 KYORIN Receives Regulatory Approval for influenza virus nucleic acid kit, GeneSoC FluAB Detection Kit February 4, 2026 Consolidated Financial Results for the Nine Months Ended December 31, 2025 - Supplementary Information February 4, 2026 Consolidated Financial Results for the Nine Months Ended December 31, 2025 [Japanese GAAP] January 5, 2026 KYORIN and Lunatus Enter into Distribution Agreement for Lasvic Tablets in Nine Middle Eastern Countries 1
About Kyorin
